Lifecore Biomedical, Inc.
Health
Performance
9.0
Risk
Sell
Buy
Curious about the Scores? Learn more.

Lifecore Biomedical, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

21.04.2026
Momentum tanked. Clearly underperforming.
18.03.2026
Rock bottom. The fall’s complete, stability nowhere to be found.
17.03.2026
Red alert. Risk levels out of control.
LFCR
Lifecore Biomedical, Inc.
4.58
-1.29%
9.0
Sell
Buy
Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Lifecore Biomedical, Inc. do? Business model and key facts

Get the full picture of Lifecore Biomedical, Inc.: what it builds, where it operates, and how it makes money.

Lifecore Biomedical, Inc. Profile

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees (FY): 382

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

shop
Company facts
Paul Josephs
CEO
382
Employees worldwide
shop
Performance
-38.44%
Last 12 months
-59.68%
Last 5 years
shop
Growth
$129.46M
Revenue year
$-30,790,291
Net income
shop
Valuation
$175.54M
Market Cap
-8.89
Price/Earnings Ratio

Stocks related to Lifecore Biomedical, Inc.

Selected based on industry alignment and relative market positioning.

EMBC
Embecta Corp.
3.25
-3.56%
8.9
Sell
Buy
Embecta Corp.
SIGA
SIGA Technologies, Inc.
3.39
-5.31%
8.6
Sell
Buy
SIGA Technologies, Inc.
SNDL
SNDL Inc.
1.27
-1.55%
7.1
Sell
Buy
SNDL Inc.
OGI
Organigram Global Inc.
0.92
-2.91%
10.0
Sell
Buy
Organigram Global Inc.
ZYBT
Zhengye Biotechnology Holding Limited
1.38
-51.58%
10.0
Sell
Buy
Zhengye Biotechnology Holding Limited

Events and news impacting Lifecore Biomedical, Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

Lifecore Biomedical, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.